Skip to main content
. 2017 Oct 19;8:179–190. doi: 10.2147/LCTT.S139647

Figure 1.

Figure 1

Study flow diagram: patients with squamous cell non-small cell lung cancer who received first-line nab-paclitaxel- or gemcitabine-based treatment.

Abbreviation: NSCLC, non-small cell lung cancer.